Kaneka acquires 96.8% of EndoStream Medical

Japan's Kaneka Corporation announced the acquisition of 96.8% of shares of Israeli medical device company EndoStream Medical, which develops the Nautilus device for aneurysm treatment. The deal is valued at an estimated $100 million, and Kaneka plans to jointly develop and manufacture new cerebrovascular devices, targeting over $120 million in sales by 2030.

“Japan's Kaneka Corporation has announced the acquisition of 96.8% of shares of Israeli medical device company EndoStream Medical Ltd. (ESM).”en.globes.co.il

• 2 sources
• en.globes.co.ilJapan's Kaneka buys Israeli co EndoStream Medical - GlobesGali WeinrebJan 9, 2025
• neuronewsinternational.comKaneka announces acquisition of Endostream MedicalJamie BellJan 10, 2025

Summarized from public sources; check the original articles before acting on it.